239 related articles for article (PubMed ID: 27693373)
1. Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis.
Iniguez E; Varela-Ramirez A; Martínez A; Torres CL; Sánchez-Delgado RA; Maldonado RA
Acta Trop; 2016 Dec; 164():402-410. PubMed ID: 27693373
[TBL] [Abstract][Full Text] [Related]
2. Searching for new chemotherapies for tropical diseases: ruthenium-clotrimazole complexes display high in vitro activity against Leishmania major and Trypanosoma cruzi and low toxicity toward normal mammalian cells.
Martínez A; Carreon T; Iniguez E; Anzellotti A; Sánchez A; Tyan M; Sattler A; Herrera L; Maldonado RA; Sánchez-Delgado RA
J Med Chem; 2012 Apr; 55(8):3867-77. PubMed ID: 22448965
[TBL] [Abstract][Full Text] [Related]
3. VOSalophen: a vanadium complex with a stilbene derivative-induction of apoptosis, autophagy, and efficiency in experimental cutaneous leishmaniasis.
Machado PA; Moraes JOF; Carvalho GSG; Lima WP; Macedo GC; Britta EA; Nakamura CV; da Silva AD; Cuin A; Coimbra ES
J Biol Inorg Chem; 2017 Aug; 22(6):929-939. PubMed ID: 28597089
[TBL] [Abstract][Full Text] [Related]
4. Antileishmanial activity of ruthenium(II)tetraammine nitrosyl complexes.
Pereira JC; Carregaro V; Costa DL; da Silva JS; Cunha FQ; Franco DW
Eur J Med Chem; 2010 Sep; 45(9):4180-7. PubMed ID: 20598778
[TBL] [Abstract][Full Text] [Related]
5. Increased ROS generation causes apoptosis-like death: Mechanistic insights into the anti-Leishmania activity of a potent ruthenium(II) complex.
Costa MS; Gonçalves YG; Teixeira SC; Nunes DCO; Lopes DS; da Silva CV; da Silva MS; Borges BC; Silva MJB; Rodrigues RS; Rodrigues VM; Von Poelhsitz G; Yoneyama KAG
J Inorg Biochem; 2019 Jun; 195():1-12. PubMed ID: 30861423
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the cytotoxic effects of ruthenium-ketoconazole and ruthenium-clotrimazole complexes on cancer cells.
Robles-Escajeda E; Martínez A; Varela-Ramirez A; Sánchez-Delgado RA; Aguilera RJ
Cell Biol Toxicol; 2013 Dec; 29(6):431-43. PubMed ID: 24272524
[TBL] [Abstract][Full Text] [Related]
7. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
[TBL] [Abstract][Full Text] [Related]
8. Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major.
Rice DR; Vacchina P; Norris-Mullins B; Morales MA; Smith BD
Antimicrob Agents Chemother; 2016 May; 60(5):2932-40. PubMed ID: 26926632
[TBL] [Abstract][Full Text] [Related]
9. Potential application of nanochitosan film as a therapeutic agent against cutaneous leishmaniasis caused by L. major.
Bahrami S; Esmaeilzadeh S; Zarei M; Ahmadi F
Parasitol Res; 2015 Dec; 114(12):4617-24. PubMed ID: 26346452
[TBL] [Abstract][Full Text] [Related]
10. Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered
Caridha D; Parriot S; Hudson TH; Lang T; Ngundam F; Leed S; Sena J; Harris M; O'Neil M; Sciotti R; Read L; Lecoeur H; Hickman M; Grogl M
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137819
[TBL] [Abstract][Full Text] [Related]
11. Anti-Leishmania activity of new ruthenium(II) complexes: Effect on parasite-host interaction.
Costa MS; Gonçalves YG; Nunes DCO; Napolitano DR; Maia PIS; Rodrigues RS; Rodrigues VM; Von Poelhsitz G; Yoneyama KAG
J Inorg Biochem; 2017 Oct; 175():225-231. PubMed ID: 28783554
[TBL] [Abstract][Full Text] [Related]
12. Auranofin is an apoptosis-simulating agent with in vitro and in vivo anti-leishmanial activity.
Sharlow ER; Leimgruber S; Murray S; Lira A; Sciotti RJ; Hickman M; Hudson T; Leed S; Caridha D; Barrios AM; Close D; Grögl M; Lazo JS
ACS Chem Biol; 2014 Mar; 9(3):663-72. PubMed ID: 24328400
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with Leishmania major.
Nahrevanian H; Hajihosseini R; Arjmand M; Farahmand M; Ghasemi F
Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1188-98. PubMed ID: 20578452
[TBL] [Abstract][Full Text] [Related]
14. Effects of combined therapy with silymarin and glucantime on leishmaniasis induced by Leishmania major in BALB/c mice.
Jabini R; Jaafari MR; Vahdati Hasani F; Ghazizadeh F; Khamesipour A; Karimi G
Drug Res (Stuttg); 2015 Mar; 65(3):119-24. PubMed ID: 24623031
[TBL] [Abstract][Full Text] [Related]
15. Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis.
Antinarelli LMR; de Oliveira Souza I; Zabala Capriles PV; Gameiro J; Britta EA; Nakamura CV; Lima WP; da Silva AD; Coimbra ES
Exp Parasitol; 2018 Dec; 195():78-86. PubMed ID: 30385267
[TBL] [Abstract][Full Text] [Related]
16. Development of a Murine Infection Model with Leishmania killicki, Responsible for Cutaneous Leishmaniosis in Algeria: Application in Pharmacology.
Eddaikra N; Kherachi Djenad I; Benbetka S; Benikhlef R; Aït-Oudhia K; Moulti-Mati F; Oury B; Sereno D; Harrat Z
Biomed Res Int; 2016; 2016():7985104. PubMed ID: 26949705
[TBL] [Abstract][Full Text] [Related]
17. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
[TBL] [Abstract][Full Text] [Related]
18. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
Halliday A; Bates PA; Chance ML; Taylor MJ
Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
